M. Baldari

Measurement of a possible patch‐testing outcome indicator

R. Gallo, E. Cozzani, V. Fausti, 2010, Contact dermatitis.

Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy

G. Argenziano, K. Peris, C. Foti, 2021, Patient preference and adherence.

Thyroid peroxidase antibodies in patients with telogen effluvium

A. Rebora, M. Guarrera, M. Baldari, 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

Distinguishing androgenetic alopecia from chronic telogen effluvium when associated in the same patient: a simple noninvasive method.

A. Rebora, M. Guarrera, M. Baldari, 2005, Archives of dermatology.

Allergic contact dermatitis from methyl gentisate in a bleaching cream

R. Gallo, M. Baldari, 2006, Contact dermatitis.

Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: results of an Experts Panel Meeting.

C. Gridelli, F. de Marinis, L. Crinò, 2008, Critical reviews in oncology/hematology.

Trichodynia is a distinguishing symptom of telogen effluvium

A. Rebora, M. Guarrera, M. Baldari, 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

Papular elastolytic giant cell granuloma: report of a case associated with monoclonal gammopathy and responsive to topical tacrolimus

A. Parodi, F. Rongioletti, M. Burlando, 2010, Clinical and experimental dermatology.

Squamomelanocytic tumor: a new case of a unique biphenotypic neoplasm of uncertain biological potential

R. Fiocca, F. Rongioletti, C. Carli, 2009, Journal of cutaneous pathology.